Patents by Inventor Michael W. Major

Michael W. Major has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzimidazole derivatives as modulators of IgE
    Publication number: 20030004203
    Abstract: This invention relates to a family of benzimidazole analogs, which are inhibitors of the IgF response to allergens. These compounds are useful in the treatment of allergy, asthma, or any diseases where IgE is pathogenic.
    Type: Application
    Filed: October 16, 2001
    Publication date: January 2, 2003
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Coumarinic compounds having IgE affecting properties
    Patent number: 6451829
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: September 17, 2002
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Benzimidazole analogs as down-regulators of IgE
    Patent number: 6369091
    Abstract: This invention relates to a family of diacyl benzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: April 9, 2002
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Compounds having IgE affecting properties
    Publication number: 20020010343
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
    Type: Application
    Filed: June 14, 2001
    Publication date: January 24, 2002
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Benzimidazole derivatives as modulators of IgE
    Patent number: 6303645
    Abstract: This invention relates to a family of diacyl benzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: October 16, 2001
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Suppression of the IgE-dependent allergic response by benzimidazole analogs
    Patent number: 6271390
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: August 7, 2001
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major